As Kennedy Champions Chronic Disease Prevention, Key Research Is Cut
The New York Times
Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration.
Robert F. Kennedy Jr. has spoken of an “existential threat” that he said can destroy the nation.
“We have the highest chronic disease burden of any country in the world,” Mr. Kennedy said at a hearing in January before the Senate confirmed him as the secretary of Health and Human Services.
And on Monday he is starting a tour in the Southwest to promote a program to combat chronic illness, emphasizing nutrition and lifestyle.
But since Mr. Kennedy assumed his post, key grants and contracts that directly address these diseases, including obesity, diabetes and dementia, which experts agree are among the nation’s leading health problems, are being eliminated.
These programs range in scale and expense. Researchers warn that their demise could mean lost opportunities to address an aspect of public health that Mr. Kennedy has said is his priority.
“This is a huge mistake,” said Dr. Ezekiel Emanuel, the co-director of the Healthcare Transformation Institute at the University of Pennsylvania’s Perelman School of Medicine.
Run 3 Space | Play Space Running Game
Traffic Jam 3D | Online Racing Game
Duck Hunt | Play Old Classic Game
Gluten-free baked goods can come out even better than the classics with this versatile DIY flour blend.
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.
After years of NASA and private crews returning to Earth near Florida, the company shifted its landing zone to the West Coast for the private Fram2 mission.
The boom in American sit-down chains has come and gone. What replaced them isn’t so great for human connection.
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
A coot’s nest reveals that what humans throw away doesn’t really go away.
American consumers are likely to see fewer choices on the shelves, and small producers may be the hardest hit.
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
Hundreds of hours of recordings suggest that the apes can generate meaning by stringing sounds together in pairs. But some scholars are skeptical.
European regulators are considering fining X more than $1 billion, after weighing the risks of further antagonizing Mr. Musk and President Trump.
With costs high and supplies short, people are getting creative with Easter egg traditions.
The reorganization that began on Tuesday will scale back an agency that has been a public health model around the world.
Cooking with the Duchess of Sussex as she navigates her rebrand from recovering royal to domestic goddess.